Clinical characteristics of the patients included in the study
Patient no. . | CD4 cell count/mm3 . | Treatment . |
|---|---|---|
| 1 | 887 | AZT-3TC-EFV |
| 2 | 566 | ddl-3TC-EFV |
| 3 | 625 | AZT-3TC-EFV |
| 4 | 593 | D4T-3TC-NFV |
| 5 | 974 | D4T-3TC-NFV |
| 6 | 626 | AZT-3TC-NFV |
| 7 | 1285 | D4T-3TC-NVP |
| 8 | 555 | ddl-TDF-LPV |
| 9 | 607 | AZT-3TC-EFV |
| 10 | 638 | AZT-3TC-NFV |
| 11 | 518 | AZT-3TC-ABC-LPV |
| 12 | 505 | 3TC-NVP-TDF |
| 13 | 518 | AZT-3TC-ABC-LPV |
| 14 | 664 | AZT-DDI-NVP |
| 15 | 555 | AZT-3TC-EFV |
Patient no. . | CD4 cell count/mm3 . | Treatment . |
|---|---|---|
| 1 | 887 | AZT-3TC-EFV |
| 2 | 566 | ddl-3TC-EFV |
| 3 | 625 | AZT-3TC-EFV |
| 4 | 593 | D4T-3TC-NFV |
| 5 | 974 | D4T-3TC-NFV |
| 6 | 626 | AZT-3TC-NFV |
| 7 | 1285 | D4T-3TC-NVP |
| 8 | 555 | ddl-TDF-LPV |
| 9 | 607 | AZT-3TC-EFV |
| 10 | 638 | AZT-3TC-NFV |
| 11 | 518 | AZT-3TC-ABC-LPV |
| 12 | 505 | 3TC-NVP-TDF |
| 13 | 518 | AZT-3TC-ABC-LPV |
| 14 | 664 | AZT-DDI-NVP |
| 15 | 555 | AZT-3TC-EFV |
The viral load was less than 50 copies/mL for patients 1 through 15. All patients have received HAART for at least 1 year. AZT indicates zidovudine; 3TC, lamivudine; EFV, efavirenz; ddl, didanosine; D4T, stavudine; NFV, nelfinavir; NVP, nevirapine; TDF, tenofovir; LPV, lopinavir; and ABC, abacavir.